Biotech: Page 32

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Researchers & Scientists

    Dr. Anish Suri Title: Senior Scientific Director, Discovery Immunology Company: Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson Education: Ph.D., Immunology, Washington University St. Louis; B.S., Biology, Angelo State University Famil...

    By PharmaVoice Team • Aug. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Fun Facts About the PharmaVOICE 100

    Where they were born? The PharmaVOICE 100 may come from all over, but what they have in common is a sincere desire to improve the lives of patients everywhere. What was their first job? We thought it would be fun to know how these highly successful executives earned their first paychecks. As it t...

    By PharmaVoice Team • Aug. 1, 2015
  • drug shopping cart Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Commercialization, marketing and social media

    As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical. 

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Overcoming the Challenges that Hinder Innovation

    PharmaVOICE 100 honorees discuss the challenges that the industry needs to overcome to support future innovation. Between 2009 and 2014, the annual growth rate for the top 25 life-sciences companies slowed from the prior decade’s double-digit average to only 1% annually, according to a recent rep...

    By PharmaVoice Team • Aug. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Innovation In a Patient-Centric World

    From healthcare reform to the push for value in medicines to personalized healthcare, the patient is now at the center of, well, everything. This means that pharmaceutical companies are now required to create a new paradigm, with the patient at the center. An initiative that began last year withi...

    By PharmaVoice Team • Aug. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    In the rare disease community there is saying: Alone we are rare, together we are strong. Wendy White, senior VP, for rare diseases, at Dohmen Life Science Services, a board member of Global Genes,  and the president of the Heathcare Businesswomen’s Association (HBA), shared her personal rare dis...

    By Taren Grom • June 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Calendar

    Coming Attractions The annual BIO International Convention, June 15-18, 2015, in Philadelphia covers the wide spectrum of life-sciences innovations and application areas. Drug discovery, biomanufacturing, genomics, biofuels, nanotechnology,  and cell therapy are just a few of the industries repre...

    By PharmaVoice Team • June 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Biopharma Pool David Allsop Amicus Therapeutics Appoints Senior VP, International Amicus Therapeutics, a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, has appointed David Allsop as senior VP, international. He is responsible for Amicus’ international organi...

    By PharmaVoice Team • June 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Biopharma Pool Steven Ertel Dr. Matthew Sherman Acceleron Pharma Announces Executive Appointments and Promotions Acceleron Pharma, a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic candidates that regulate cellular growth...

    By PharmaVoice Team • May 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    2015 HBA Luminaries

    The Importance of Mentoring and Sponsorship Emily Lightfoot. AmerisourceBergen. Relationships with mentors have been the key to my career success. Having an advocate and coach to help me plan my career, discover my strengths, and identify opportunities has helped me develop confidence to take on ...

    By Taren Grom • May 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma Trax

    Venture Funding Trends Trending now: Report shows an increase in funding for rare diseases and a decrease in funding for chronic diseases. Seventy-eight percent of U.S. venture investment for therapeutics went toward novel drug R&D, suggesting innovation is a core priority for venture investo...

    By PharmaVoice Team • April 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Biotechnology Pool Mary Thistle Dimension Names Chief Business Officer Dimension Therapeutics, a rare disease company advancing novel treatments for diverse genetic disorders of the liver based upon an AAV gene therapy platform, has appointed Mary Thistle to the newly created position of chief bu...

    By PharmaVoice Team • April 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Biotechnology Pool Tony Hunt Repligen Names CEO Repligen, a life-sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs, has appointed Tony Hunt as CEO. Mr. Hunt, currently Repligen’s chief operatin...

    By PharmaVoice Team • March 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive appointments and promotions in the healthcare industry Pharma Pool Dr. Julie Gerberding Merck Strengthens Executive Team Merck has named Julie Gerberding, M.D., as executive VP for strategic communications, global public policy and population health. In this newly created executive comm...

    By PharmaVoice Team • Feb. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Addressing the Needs of THOSE WITH RARE DISEASES Peter Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), talks about recent orphan drug approvals. PV: 2014 was a record year for orphan drug approvals. What are your predictions for the orphan drug space for 201...

    By Peter Saltonstall • Feb. 1, 2015
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    R&D Crowdsourcing: Crowdsourcing in Pharma

    Companies are looking at nontraditional ways of collaborating to access new insights that could lead to innovative therapies. There is a growing movement within the industry toward open access and crowdsourcing scientific information to accelerate research and development. This open environment r...

    By Denise Myshko • Nov. 15, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE FEATURE: E-Solutions: Power Surge

    E-Solutions ranging from mobile advances to EMR technologies are expected to reframe the patient model. Notably, the most encouraging news on mobile and quantified health is the recent announcement and launch of the HealthKit platform and the mobile app Health by Apple. HealthKit allows devices a...

    By Taren Grom • Nov. 15, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Year in Preview: On the Horizon: Looking Ahead…

    Experts from across all sectors of the industry provide their input on the trends in 2015 that will have the biggest impact on the industry, and how they will shape the future of healthcare. For this year’s special Year in Preview issue we took a slightly different tact than in years past. We are...

    By Taren Grom • Nov. 15, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Biotech Pool Dr. Annalisa Jenkins Dimension Therapeutics Names CEO Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, has apppointed Annalisa Jenkins, MBBS, MRCP, CEO. Dr. Jenkins succeeds interim CEO Thomas Beck. Dr. Jenkins brings to Dimensi...

    By Ann Grey • Nov. 15, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Electronic Health Record: A Focus On Patient Benefits

    When we think of the positive impact of electronic health record (EHR) adoption, we often focus on the increased efficiency of the medical practice or additional convenience for healthcare providers (HCPs). We do not often associate those benefits with our most important target: the patient. Curr...

    By Eugene Lee • Sept. 27, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Embracing Co-Creation to Better Connect

    Many patient and caregiver campaigns fail to resonate with their intended audiences. Innovative collaboration methods and co-creation with patients and caregivers can add authenticity to communications and elevate brands. Do you remember the telephone game when you were a kid? One person starts t...

    By Dan Bobear • Sept. 27, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Transdermal Delivery: Winning Patient Preference

    The pharma landscape continues to be crowded and competitive, with more emphasis than ever before on delivering improved patient outcomes at a competitive price. In light of this, pharmaceutical companies must not only deliver products that effectively treat patients’ problems, but also prioritiz...

    By Ingrid Blair • Sept. 27, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE FEATURE: Patient Solutions

    As healthcare systems begin to pay for outcomes rather than ­products, patient-centric solutions and services will play a key role in the race to capture value. From wearables to improved drug delivery devices, from apps to EHR platforms, from patient trackers to packaging, the number of solution...

    By Taren Grom • Sept. 27, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Vested Outsourcing Imperative

    Managing the Talent Supply Chain Large life sciences companies today face many challenges in acquiring and managing talent to meet their business imperatives. The first decision to be made is always the same, whether the workforce contains full-time employees, contingent workers, independent cont...

    By Kevin D. Duffy • Sept. 27, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE FEATURE: Supply Chain: Talent Management: A Different Supply Chain Issue

    A sound workforce strategy furthers a company’s business agenda and generates results. When the topic of supply chain management is discussed, the conversation typically is about manufacturing and distribution issues. But today one of the most pressing challenges facing CEOs is the talent supply ...

    By Taren Grom • Sept. 27, 2014
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Colombia Emerges as an Attractive Pharma Market

    With a growing interest in attracting R&D and continual economic growth, Colombia is seen as an attractive market for pharmaceutical companies. The Republic of Colombia is evolving from an emerging economy, having enjoyed an economic turnaround since 2000, when it was perceived by economists ...

    By Kim Ribbink • Sept. 27, 2014